Recombinant Measles and Vesicular Stomatitis Virus are Ideal Adjunct to Checkpoint Immunotherapy

Stephen J. Russell, MD, PhD of Mayo Clinic explains why recombinant measles and recombinant vesicular stomatitis virus are ideal adjunct to checkpoint immunotherapy. Both have shown impressive activit... Author: ASCO-SITC2017 Added: 03/06/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts